癌症患者路径对胶质母细胞瘤患者放疗时机和生存的影响:一项队列研究
研究纳入挪威东南部卫生局2006至2019年诊断并接受放疗的1212例胶质母细胞瘤患者,比较癌症患者路径实施前后放疗时机与生存。路径实施后术后4周内接受放疗的比值显著更高(p<0.001),中位总生存12.9个月,路径实施后时期生存显著更长,但术后放疗时机(<4周、4-6周、>6周)对生存无影响(p=0.349)。
要点
- 癌症患者路径实施后术后4周内放疗的比值显著更高(p<0.001)。
- 中位总生存12.9个月,路径实施后时期生存显著更长。
- 术后放疗时机(<4周、4-6周、>6周)对生存无显著影响(p=0.349)。
核心结论
- 癌症患者路径实施显著缩短了术后开始放疗的时间。
- 路径实施后时期生存显著更长,但术后放疗时机相对于手术时间对生存无影响。
研究设计与样本
- 研究纳入挪威东南部地区卫生局2006至2019年诊断并接受放疗的连续胶质母细胞瘤患者,共1212例。
- 路径实施前组为2006-2014年诊断患者,路径实施后组为2016-2019年诊断患者。
主要发现
- 路径实施与显著更好的结局相关(p<0.001)。
- 中位总生存为12.9个月。
- 路径实施后术后4周内接受放疗的比值显著更高(p<0.001)。
- 术后放疗时机<4周、4-6周或>6周之间生存无差异(p=0.349)。
- 校正分析中预后较好因素包括女性(p=0.005)、较年轻年龄(p<0.001)、单发肿瘤(p=0.008)、全切(p<0.001)和较高放疗剂量(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GBM) is an aggressive brain tumor in which primary therapy is standardized and consists of surgery, radiotherapy (RT), and chemotherapy. However, the optimal time from surgery to start of RT is unknown. A high-grade glioma cancer patient pathway (CPP) was implemented in Norway in 2015 to avoid non-medical delays and regional disparity, and to optimize information flow to patients. This study investigated how CPP affected time to RT after surgery and overall survival. METHODS: This study included consecutive GBM patients diagnosed in South-Eastern Norway Regional Health Authority from 2006 to 2019 and treated with RT. The pre CPP implementation group constituted patients diagnosed 2006-2014, and the post CPP implementation group constituted patients diagnosed 2016-2019. We evaluated timing of RT and survival in relation to CPP implementation. RESULTS: A total of 1212 patients with GBM were included. CPP implementation was associated with significantly better outcomes (p < 0.001). Median overall survival was 12.9 months. The odds of receiving RT within four weeks after surgery were significantly higher post CPP implementation (p < 0.001). We found no difference in survival dependent on timing of RT below 4, 4-6 or more than 6 weeks (p = 0.349). Prognostic factors for better outcomes in adjusted analyses were female sex (p = 0.005), younger age (p < 0.001), solitary tumors (p = 0.008), gross total resection (p < 0.001), and higher RT dose (p < 0.001). CONCLUSION: CPP implementation significantly reduced time to start of postoperative RT. Survival was significantly longer in the period after the CPP implementation, however, timing of postoperative RT relative to time of surgery did not impact survival.
引用
- Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, et al. The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients. J Neurooncol. 2024. PMID: 38762830. doi:10.1007/s11060-024-04709-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。